STAT3 and neoplasm: VEGF, IL-6 and IL-10, which are usually overexpressed in TME, can activate STAT3 signaling, thereby inducing an immature tolerance phenotype in tumor-associated DCs and promoting tumor progression (Nefedova et al., 2004; Yu et al., 2009).